Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-22

FDA Approved: OPVEE — Original Application (Indivior Inc.)

View source ↗

Summary

The FDA approved OPVEE (nalmefene hydrochloride) from Indivior as a new drug via an original NDA; it is indicated for the treatment of alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPVEE (Nalmefene hydrochloride)

Snippet

ORIG AP for OPVEE (NALMEFENE HYDROCHLORIDE)